Apply for the Epidemic Science Leadership and Innovation Networks

Apply for the Epidemic Science Leadership and Innovation Networks. At any one time, the African continent experiences 100 or more ongoing disease outbreaks. As Africa undergoes rapid demographic growth, as the continent becomes increasingly connected, and as environmental degradation persists, the risks of outbreaks and novel disease emergence will likely intensify.

Investment in African epidemic and pandemic sciences research and preparedness will protect and enhance national and regional healthcare systems and help to safeguard African economic stability by mitigating adverse socio-economic impacts. Developing a thriving epidemic and pandemic sciences sector across academia, industry, government and policy organisations, and preparing an emerging generation of high-calibre scientists, policymakers, and healthcare leaders in Africa will enhance health security and economic prosperity on the continent, and leverage African expertise to influence epidemic and pandemic research, preparedness and response priorities at a global level.

EPSILONs

This call will foster a vibrant ecosystem of Epidemic Science Leadership and Innovation Networks (EPSILONs) across Africa. Each EPSILON will comprise three to eight organisations in a ‘hub and spoke’ consortium. Each consortium will establish a network of research excellence in a thematic area relevant to epidemic and pandemic sciences research, preparedness and response. 

These networks will nurture and promote world-class epidemic and pandemic sciences research and innovation in Africa, building a critical mass of experts across all health sectors in the continent to address ongoing health challenges while strengthening capabilities to respond to future infectious diseases health threats. They will contribute to developing communities of practice that may be leveraged for long-term collaboration and during future outbreaks to respond to urgent research and policy needs.

Impact areas

Impact

Increased health, resilience and wellbeing among the African and global population

Long term outcomes

1. Epidemics and pandemics in Africa effectively predicted, prevented and managed
2. Health, social and economic impacts of epidemics and pandemics in Africa effectively mitigated
3. A vibrant epidemics and pandemics science ecosystem in Africa undertaking high-quality research and innovation

Medium term outcomes

1. Increased translation and uptake of epidemics and pandemics research outputs into contextually relevant solutions, regulations, approaches and policies
2. Sustainable career pathways for young researchers and professionals working on epidemics and pandemics
3. Enhanced professionalism and a well-resourced (financial and human resources) epidemics and pandemics sector to support research in Africa

Short term outcomes

1. Enhanced epidemics and pandemics scientific research quality
2. Increased innovations to address epidemics and pandemics trends
3. Young researchers transitioning to dignified and fulfilling work at scale
4. Increased engagement and collaboration leveraging areas of synergy in epidemics and pandemics research, policy and practice
5. Increased leadership influence of African epidemics and pandemics researchers across science networks, local communities, funding partners, private sector, industry and policy actors
6. Supportive professional service and research management culture and structures in place across institutions
7. Young professionals transitioning to dignified and fulfilling work at scale

Eligibility

Applicant eligibility

Lead applicants can lead only one application but may be co-applicants in several applications. Lead applicants must be based at an eligible organisation and must fulfil the following conditions:

Hold an academic or research post; Have a salary, or the guarantee of a salary, for the duration of the award period, or be required by their contract of employment to have a salary;

Thematic research areas

• Vaccinology / early-stage vaccine research and development
• Virology – genotype to phenotype
• Clinical research and clinical trials on epidemic and pandemic prone infections
• Epidemic and pandemic public health policy research
• Climate change, biodiversity and pandemic prevention
• Advanced data assembly and analytics for threat assessment and mitigation
• Social and behavioural sciences

Budget

Applicants should prepare a core budget for up to USD $4 million over five to six years, plus specific additional elements as detailed in the call guidelines. It is anticipated that successful consortia will attract additional funding from other sources over the duration of the programme. 

For more details about impact areas, please refer to the call guidelines.

Key Information for Applications at Preliminary Stage